FDA Leadership and Policy Challenges Amidst Turmoil
TL;DR
The FDA faces significant challenges including leadership turnover, internal conflicts, politicization, and low morale, raising concerns about its stability and future direction as it approaches 2026, with uncertainty surrounding Commissioner Marty Makary's role.
- 3 key issues to watch at FDA as Makary struggles to stabilize the agency statnews.com
- F.D.A. Turmoil Keeps Spotlight on Its Commissioner The New York Times
- Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients Forbes
- FDA Faces Challenges in Vaccine Policy, Deregulation, and Leadership Stability Under Commissioner Makary geneonline.com
- A Prescription for Success at the FDA RealClearHealth
Want the full story? Read the original reporting
Read on statnews.com